tirzepatide under the tongue FDA has approved a new multi-dose KwikPen delivery option for weekly injectable obesity treatment. This label expansion allows patients and providers to choose between: • Single-dose autoinjectors • Multi-dose KwikPen (four Oral tirzepatide: what actually exists,

Hiromura M, Mori Y, Kohashi K, et al

Patients taking semaglutide showed considerable improvement compared to those on placebo, potentially positioning semaglutide as a promising option for MASH

Cycle guidelines Cycle guidelines Approach Phase 2 reference Duration 48 weeks Review Point Every 4 weeks at each dose step Best For Matches the original NEJM trial structure Approach Phase 3 TRIUMPH reference Duration 68-72 weeks Review Point Every 4 weeks

A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabete

Until then, experts are generally skeptical that GLP-1 RAs are a good idea for athletes who dont medically need them